Patents by Inventor Li Zhou

Li Zhou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12174133
    Abstract: An X-ray-based test device for a plugging removal effect of a sulfur dissolvent on a sulfur deposition rock sample includes a constant speed and pressure pump, a first intermediate container, a second intermediate container, a first pressure transmitter, a core holder, a second pressure transmitter, a first electric pump, a third intermediate container, a back-pressure valve, a gas flow meter, an H2S neutralization tank, a second electric pump, a back-pressure transmitter, a confining pressure transmitter, an X-ray generator, an X-ray detector and a thermotank. A sour gas sample is placed in the first intermediate container, and nitrogen is filled in the second intermediate container. The sulfur dissolvent is placed into the third intermediate container. A confining pressure inlet is formed in the core holder. The test device may be used for evaluating the plugging removal effect of the sulfur dissolvent injected into the sulfur deposition rock sample.
    Type: Grant
    Filed: December 16, 2022
    Date of Patent: December 24, 2024
    Assignee: Southwest Petroleum University
    Inventors: Xiao Guo, Pengkun Wang, Tao Li, Jingjing Ma, Changqing Jia, Li Zhou, Ming Zhou, Yi He, Bing Kong, Linkai Li, Lan Wang
  • Publication number: 20240415910
    Abstract: A toxicity-removed and medicinal effect-retained Fuzi decoction granule and a preparation method thereof are provided, belonging to the technical field of traditional Chinese medicine preparation. The preparation method of the toxicity-removed and medicinal effect-retained Fuzi decoction granule includes the following steps: subjecting Radix Aconiti Lateralis Preparata to immersion and decoction in advance for 60 min to 120 min, and then mixing with Poria, Radix Ginseng, bran-fried Rhizoma Atractylodis Macrocephalae, Radix Paeoniae Alba, Radix Paeoniae Rubra, and Ramulus Cinnamomi to allow immersion for 30 min to 60 min; and subjecting a filtrate obtained by filtration to concentration and granulation in sequence to obtain the toxicity-removed and medicinal effect-retained Fuzi decoction granule. The Fuzi decoction granule prepared by the preparation method can remove inherent toxicity and retain a medicinal effect on osteoarthritis.
    Type: Application
    Filed: June 14, 2024
    Publication date: December 19, 2024
    Inventors: Letian SHAN, Li ZHOU
  • Publication number: 20240374569
    Abstract: The present disclosure provides methods for the prevention and treatment of Langerhans cell sarcoma (LCS) and Langerhans cell histiocytosis (LCH) in a subject comprising administering an effective or therapeutically effective dose of a HDAC3 inhibitor to the subject in need thereof.
    Type: Application
    Filed: September 22, 2022
    Publication date: November 14, 2024
    Inventors: Qing-Sheng MI, Li ZHOU
  • Publication number: 20240376524
    Abstract: The present invention provides a method for integrating a nucleic acid analysis system and measuring at least one target nucleic acid in a sample. The integrated nucleic acid analysis system includes one DMF device, which includes a substrate, a cover plate, and an instrument for performing a series of operations including magnetic beads based nucleic acid extraction, purification, thermal amplification, and optical measurement of nucleic acids in samples in a DMF device. The nucleic acid extraction and purification are based on the magnetic bead method, which uses instruments to move magnetic beads in different functional areas of the digital microfluidic chip, such as lysis reservoirs, cleaning reservoirs, and elution reservoirs, etc. The present invention integrates sample processing and detection on the same microfluidic chip, and the entire process is automatically completed by the corresponding instrument.
    Type: Application
    Filed: November 1, 2021
    Publication date: November 14, 2024
    Applicants: Shanghai Hengxin BioTechnology Limited, Ningbo Hengxin BioTechnology Limited
    Inventors: Chuanyong WU, Li ZHOU, Zhifang WANG
  • Publication number: 20240368219
    Abstract: Novel cyclic ?-AA peptides and methods of use thereof in modulating E3 activity are presented. Each novel compound is comprised of four ?-AA building blocks. It was found that in particular, compound P6 activated E6AP to stimulate self-ubiquitination of E6AP and E6AP-catalyzed substrate ubiquitination as well as enhance the ubiquitination of E6AP substrates in the cell and accelerate their degradation.
    Type: Application
    Filed: July 18, 2024
    Publication date: November 7, 2024
    Inventors: Jianfeng Cai, Bo Huang, Jun Yin, Li Zhou, Ruochuan Liu
  • Publication number: 20240352016
    Abstract: Provided are compounds as potent inhibitors of cyclin-dependent kinase (CDK), or pharmaceutically acceptable salts thereof. Corresponding compositions are also provided.
    Type: Application
    Filed: August 10, 2022
    Publication date: October 24, 2024
    Inventors: Lei Mo, Junkai Huang, Kai Li, Li Zhou, Xiaohui Hu
  • Publication number: 20240351213
    Abstract: A collaborative-manipulation robotic arm for kitchen waste and a working method thereof are provided. The robotic arm includes: a base, including a transverse first mounting seat and a second mounting seat connected to the first mounting seat and extending downward; a driving mechanism, disposed at an end of the first mounting seat away from the second mounting seat; a front guide claw, an upper end of the front guide claw being connected to the driving mechanism; a fixed blade, disposed on a side of the second mounting seat facing the front guide claw; and a retractable finger, disposed at a lower end on the side of the second mounting seat facing the front guide claw. The fixed blade, the retractable finger, and the second mounting seat form a rear cutting claw.
    Type: Application
    Filed: June 27, 2024
    Publication date: October 24, 2024
    Applicant: HUNAN UNIVERSITY
    Inventors: Qiaokang LIANG, Hai QIN, Songyun DENG, Zhanjin DENG, Li ZHOU, Yaonan WANG, Wei SUN
  • Publication number: 20240353378
    Abstract: The present invention provides a device and method for analyzing quality indicators of a natural gas product and an application.
    Type: Application
    Filed: July 1, 2024
    Publication date: October 24, 2024
    Inventors: Li ZHOU, Xiaoqin WANG, Wenping ZENG, Lin SHEN
  • Patent number: 12123007
    Abstract: The present disclosure discloses a method for constructing an efficient Bacillus subtilis promoter, and belongs to the technical field of gene engineering. According to the present disclosure, natural promoters identified by different sigma subunits are connected in series to obtain some double-series and triple-series promoters, the lengths of intervening sequences between core areas of the promoters are optimized on the basis of series connection of the promoters to further improve the activity of the promoters, finally, different RBS designs are performed on the promoters, and it is verified that this strategy can not only improve the compatibility between the promoters and other gene expression regulating and controlling elements, but also controllably regulate the expression of exogenous genes.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: October 22, 2024
    Assignee: Jiangnan University
    Inventors: Zhemin Zhou, Wenjing Cui, Laichuang Han, Zhongmei Liu, Li Zhou, Junling Guo, Yu Yan
  • Publication number: 20240342283
    Abstract: An ROR1 CAR or ROR1/CD19 Dual CAR for the treatment of tumors. The T cells expressing ROR1 CAR or ROR1/CD19 Dual CAR can be stimulated by ROR1-positive or ROR1/CD19-positive cells, and have cytotoxicity against ROR1-positive or ROR1/CD19-positive cells.
    Type: Application
    Filed: August 15, 2022
    Publication date: October 17, 2024
    Inventors: Mengqi Zong, Jie Jiao, Jianxia Feng, Michael Harris, Xin Kai, Li Zhou, Ninghai Wang, Liangjun Wei, Hao Chen, Xian Wen, Changlin Dou, Chuangchuang Dong
  • Publication number: 20240336903
    Abstract: The present application provides novel fusion proteins for dephosphorylating proteins that regulate T cell activation through the TCR signaling pathway, nucleic acids encoding said proteins, vectors comprising said nucleic acids, compositions comprising said nucleic acids or vectors, host cells comprising said nucleic acids, vectors or compositions or related pharmaceutical compositions. The present application also provides methods for dephosphorylation of proteins that regulate T cell activation through the TCR signaling pathway of a cell, methods of producing a cell having dephosphorylated proteins that regulate T cell activation through the TCR signaling pathway (e.g. a CAR T cell having dephosphorylated Immunoreceptor Tyrosine-based Activation Motifs (ITAMs) of endogenous CD3), methods of treating a disease, and methods of reducing or preventing GvHD in a subject associated with the administration of one or more CAR T-cells to the subject.
    Type: Application
    Filed: August 18, 2022
    Publication date: October 10, 2024
    Inventors: Michael Harris, Ninghai Wang, Li Zhou, Feng Shi
  • Publication number: 20240332910
    Abstract: A high-efficiency active layer includes a strained quantum well layer and, at one side thereof, a first strained barrier layer configured to transport electrons. The first strained barrier layer and the strained quantum well layers are configured to form strain compensation. A second barrier layer is positioned on the other side of the strained quantum well layer and is configured to transport holes. A band offset between conduction bands of the first strained barrier layer and of the strained quantum well layer is less than a band offset between valence bands of the strained quantum well layer and of the first strained barrier layer. A band offset between valence bands of the strained quantum well layer and of the second barrier layer is less than a band offset between conduction bands of the second barrier layer and of the strained quantum well layer. Light-emitting efficiency and reliability are improved.
    Type: Application
    Filed: May 29, 2023
    Publication date: October 3, 2024
    Applicants: SUZHOU EVERBRIGHT PHOTONICS CO., LTD., EVERBRIGHT INSTITUTE OF SEMICONDUCTOR PHOTONICS CO., LTD.
    Inventors: Jun WANG, Shaoyang TAN, Li ZHOU, Yang CHENG, Xiao XIAO, Yintao GUO, Hao YU, Quanling LI, Xinsheng LIAO, Dayong MIN
  • Patent number: 12104189
    Abstract: The disclosure discloses a mutant of nitrile hydratase derived from Caldalkalibacillus thermarum, and belongs to the technical field of enzyme engineering. The nitrile hydratase mutant Cal. t Nhase-A20V provided by the disclosure has a half-life of about 10 min at 70° C., which does not change much compared with the thermal stability of the wild enzyme. The specific enzyme activity of the mutant Cal. t Nhase-A20V is 128% of that of the wild enzyme. At the same time, the mutant also has better tolerance to a substrate and a product, and the final yield of nicotinamide produced by whole-cell catalysis reaches 598 g/L. Therefore, the nitrile hydratase mutant Cal. t Nhase-A20V provided by the disclosure has good enzymatic properties and is beneficial to future industrial production.
    Type: Grant
    Filed: August 11, 2021
    Date of Patent: October 1, 2024
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Zhemin Zhou, Zhongmei Liu, Ting Li, Dezhi Chen, Sailan Zhang, Li Zhou, Wenjing Cui, Zhongyi Cheng, Junling Guo
  • Publication number: 20240317857
    Abstract: Provided in the present invention is an antibody against human CD3 or an antigen-binding fragment thereof; also provided are a nucleic acid molecule encoding the antibody, an expression vector expressing the antibody and a host cell, as well as a method for producing the antibody. In addition, also provided in the present invention are a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, a use thereof in the preparation of a drug, and a use of the drug as a drug for the prevention and/or treatment of various diseases, including tumors, organ transplantation and autoimmune diseases.
    Type: Application
    Filed: June 17, 2022
    Publication date: September 26, 2024
    Applicant: AMPSOURCE BIOPHARMA SHANGHAI INC.
    Inventors: Cui Wu, Yongjuan Gao, Li Zhou, Jiasheng Diao, Xinlu Ma, Zhao Dong, Qiang Li
  • Publication number: 20240319814
    Abstract: This application discloses a touch panel and a human-computer interaction method based on a touch panel. The touch panel includes a base substrate, at least one pressure detector and at least one actuator arranged on the base substrate, and a driving circuit. The at least one pressure detector is electrically connected to the driving circuit, and the driving circuit is electrically connected to the at least one actuator.
    Type: Application
    Filed: April 28, 2022
    Publication date: September 26, 2024
    Inventors: Shuai WANG, Dexing QI, Hui HUA, Yingzi WANG, Dongsheng HUANG, Li ZHOU, Xiaoguang XU
  • Patent number: 12098373
    Abstract: The present disclosure discloses a Bacillus subtilis efficiently-induced expression system based on an artificial series promoter, and belongs to the technical field of gene engineering. According to the present disclosure, an efficient artificial series constitutive promoter is used, and by compositely designing the promoter and elements (a repressor and a binding site thereof) relevant to an operon, the activity of the constitutive promoter is regulated and controlled by an inducer to finally construct the B. subtilis efficiently-induced expression system induced by the inducer. The result indicates that compared with a P43 strongly constitutive promoter, the activity of the artificial series promoter in the system is about 15 times higher. The activity of the promoter can be accurately controlled by adding different concentrations of inducers.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: September 24, 2024
    Assignee: JIANGNAN UNIVERSITY
    Inventors: Zhemin Zhou, Wenjing Cui, Laichuang Han, Wenliang Hao, Li Zhou, Zhongmei Liu, Yu Yan
  • Publication number: 20240309135
    Abstract: An aqueous dispersion contains multistage polymeric particles and optionally a polyfunctional carboxylic hydrazide containing at least two hydrazide groups per molecule, where the multistage polymeric particles are prepared by a multistage free-radical polymerization process comprising: (i) preparing a first polymer by a free-radical polymerization, followed by neutralizing the first polymer to a pH value of greater than 7.1; and (ii) preparing a second polymer in the presence of the neutralized first polymer obtained from step (i), to obtain the multistage polymeric particles comprising the first polymer and the second polymer at a weight ratio of the first polymer to the second polymer of from 27:73 to 60:40; where the first polymer comprises from 6% to 18% of structural units of an acid monomer, a salt thereof, or mixtures thereof; from 1.
    Type: Application
    Filed: September 30, 2021
    Publication date: September 19, 2024
    Inventors: Xiaohong Yang, Jinfei Wang, Li Zhou, Juan Zhao
  • Patent number: 12082910
    Abstract: Systems and methods are described herein for utilizing a photoacoustic sensor for estimating analyte concentration levels. Also described here are training methods for training an analyte sensor to more accurately estimate an analyte concentration level on the basis of a received acoustic signal.
    Type: Grant
    Filed: July 29, 2020
    Date of Patent: September 10, 2024
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Li Zhou, Raymond M. Russell, Peter Schultz, Anuj M. Patel, Carol Chen, Roshanne Malekmadani, Lynette To, Hsiao-Yu S. Kow, Raghavendhar Gautham
  • Publication number: 20240293907
    Abstract: The present application discloses a positioning adjustment method, a positioning tool, an apparatus, a device, and a storage medium. The positioning adjustment method includes: determining a target movement distance according to target position information and start position information of the adjusted member; and moving an adjusted member to a target position according to the target movement distance.
    Type: Application
    Filed: May 15, 2024
    Publication date: September 5, 2024
    Applicant: ZHUHAI TITANS NEW POWER ELECTRONICS CO., LTD.
    Inventors: Rui WANG, Xinhua HUANG, Li ZHOU
  • Patent number: 12079719
    Abstract: A deep learning model implements continuous, lifelong machine learning (LML) based on a Bayesian neural network using an inventive framework including wide, deep, and prior components that employ diverse algorithms to leverage available real-world healthcare data differently to improve prediction performance. The outputs from each component of the framework are fed into a wide and shallow neural network and the posterior structure of the final model output may be utilized as a prior structure when the deep learning model is refreshed with new data in a deep learning process. Lifelong learning is implemented by dynamically integrating present learning from the wide and deep learning components with past learning from traditional tree models in the prior component into future predictions. Thus, the present Bayesian deep neural network-based LML model increases accuracy in identifying patient profiles by continuously learning, as new data become available, without forgetting prior knowledge.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: September 3, 2024
    Assignee: IQVIA Inc.
    Inventors: Guanhao Wei, Yunlong Wang, Li Zhou, Lynn Lu, Emily Zhao, Lishan Feng, Fan Zhang, Frank Jing, Yilian Yuan